The million-euro operation involving Barcelona-based telemedicine company and new Catalan and Spanish ministers, just some of the noteworthy headlines this June
This month, researchers in the BioRegion have published articles in the highest impact science journals, while pharmaceutical and biotechnology companies have advanced their growth plans and drugs
Publications in top journals, rounds of investment, licensing, benchmark events held in Barcelona... 2017 was a year full of good news for the BioRegion of Catalonia. Saying goodbye to the EMA and the political instability were the bittersweet counterpoint. What can we learn from these successes and failures? From research, enterprise and management, some of the main figures take stock.